DNLI (STOCKS)
Denali Therapeutics Inc. Common Stock
$24.820000
-0.450000 (-1.78%)
Prev close: $25.270000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ryan J. Watts
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,330.73M
- Employees
- 517
- P/E (TTM)
- -8.75
- P/B (TTM)
- 4.83
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
11
Strong Buy
13
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.68 | $-0.67 | -0.0101 | -1.51% |
|
Mar 2026 (Q1)
|
$-0.69 | $-0.74 | +0.0505 | +6.82% |
|
Dec 2025 (Q4)
|
$-0.73 | $-0.76 | +0.0290 | +3.82% |
|
Sep 2025 (Q3)
|
$-0.74 | $-0.77 | +0.0269 | +3.51% |
Financial Statements
| Revenues | $3.60M |
| Operating Expenses | $546.21M |
| Research and Development | $400.72M |
| Other Operating Expenses | $109.21M |
| Operating Income/Loss | -$542.70M |
| Income/Loss From Continuing Operations After Tax | -$511.45M |
| Income/Loss From Continuing Operations Before Tax | -$523.25M |
| Net Income/Loss | -$511.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$511.45M |
| Net Income/Loss Available To Common Stockholders, Basic | -$511.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.84 |
| Diluted Earnings Per Share | -$2.84 |
| Basic Average Shares | 360,346,018 |
| Diluted Average Shares | 360,346,018 |
| Assets | $1.16B |
| Current Assets | $753.93M |
| Inventory | $4.14M |
| Other Current Assets | $749.79M |
| Noncurrent Assets | $404.03M |
| Fixed Assets | $49.93M |
| Intangible Assets | $35.25M |
| Other Non-current Assets | $318.85M |
| Liabilities | $322.78M |
| Current Liabilities | $90.08M |
| Accounts Payable | $11.81M |
| Wages | $13.42M |
| Other Current Liabilities | $64.85M |
| Noncurrent Liabilities | $232.69M |
| Equity | $835.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $835.18M |
| Liabilities And Equity | $1.16B |
| Net Cash Flow From Operating Activities | -$434.04M |
| Net Cash Flow From Operating Activities, Continuing | -$434.04M |
| Net Cash Flow From Investing Activities | $68.98M |
| Net Cash Flow From Investing Activities, Continuing | $68.98M |
| Net Cash Flow From Financing Activities | $425.38M |
| Net Cash Flow From Financing Activities, Continuing | $425.38M |
| Net Cash Flow | $60.32M |
| Net Cash Flow, Continuing | $60.32M |
| Comprehensive Income/Loss | -$514.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$514.36M |
| Other Comprehensive Income/Loss | -$514.36M |
| Other Comprehensive Income/Loss Attributable To Parent | -$2.91M |